SEARCH

SEARCH BY CITATION

Figure S1 and S2. Detection of phosphatidylserine exposure in the primary melanoma cell lines WM35 and WM115 by annexin V staining.

Figure S3 and S4. Detection of phosphatidylserine exposure in the metastatic melanoma cell lines Skmel2 and Skmel28 by annexin V staining.

Figure S5. Detection of phosphatidylserine exposure in Skmel2 cells using a different sh-CRD-BP construct.

Figure S6. Detection of phosphatidylserine exposure in normal human melanocytes by fluorescence staining.

Figure S7. Disruption of CRD-BP and MITF expression by sh-CRD-BP.

Figure S8. Effect of CRD-BP inhibition and MITF overexpression on the anti-growth response to chemotherapeutics used at low concentrations.

Figure S9. NFκB activation, MDR-1 and c-myc expression in the presence and absence of CRD-BP.

Appendix S1. Methods.

FilenameFormatSizeDescription
PCMR_921_sm_AppS1.docx22KSupporting info item
PCMR_921_sm_AppS2.docx16KSupporting info item
PCMR_921_sm_fs1.tif2191KSupporting info item
PCMR_921_sm_fs2.tif1607KSupporting info item
PCMR_921_sm_fs3.tif1894KSupporting info item
PCMR_921_sm_fs4.tif3043KSupporting info item
PCMR_921_sm_fs5.tiff398KSupporting info item
PCMR_921_sm_fs6.tif1038KSupporting info item
PCMR_921_sm_fs7.tif218KSupporting info item
PCMR_921_sm_fs8.tif407KSupporting info item
PCMR_921_sm_fs9.tif318KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.